Equaline Lansoprazole Capsule, Delayed Release
Product Images NDC 41163-150

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Equaline Lansoprazole (NDC 41163-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Natural Foods, Inc. Dba Unfi, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Image 1 (Image 01)

This is a comparison of two acid reducers delayed-release capsules belonging to different brands, Equaline® and iot Pharmaceuticals. Both have the same ingredients, amounts, and effect, with the same dose of 15 mg of lansoprazole. These delayed-release capsules can take up to four days for full effect and are sodium-free. They are efficient in treating frequent heartburn, and a single course of treatment involves taking 14 capsules. The label mentions that the drug is manufactured and distributed by Iot Pharmaceuticals, which owns the registered trademark Prevaci®.*

FDA Label Image

Lansoprazole Image 2 (Image 02)

This is a drug information sheet for a lansoprazole 15 mg acid reducer used to treat frequent heartburn. The sheet includes directions for use and warnings, such as seeking medical advice if heartburn persists, not using if allergic to lansoprazole, and keeping the product out of children's reach. It is recommended to read the package insert for important information, store the product at the right temperature, and protect it from moisture. Inactive ingredients are also listed, and the product is labeled gluten-free.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.